Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-25

Clinical Trial Update: RCT of Ghrelin in Stroke Patients [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating ghrelin in patients with ischemic stroke; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ghrelin (ghrelin)

Snippet

Sponsor: Rijnstate Hospital | Conditions: Stroke, Ischemic | Phase 2 | Status: UNKNOWN